Syngene International Ltd updates on USFDA inspection at Bengaluru facilities

The USFDA conducted a pre-approval and cGMP inspection covering commercial manufacturing activities for the US market, at the Bengaluru facilities from February 10, 2025 till February 20, 2025. On conclusion of the inspection, the USFDA issued Form 483 with 5 (Five) observations. The Company will work closely with USFDA and remains committed to addressing these observations comprehensively within the stipulated time.

Shares of Syngene International Limited was last trading in BSE at Rs. 713.95 as compared to the previous close of Rs. 714.90. The total number of shares traded during the day was 7338 in over 1237 trades.

The stock hit an intraday high of Rs. 725.50 and intraday low of 705.00. The net turnover during the day was Rs. 5243753.00.

Source : Equity Bulls

Keywords

SyngeneInternational INE398R01022 USFDA Inspection Bengaluru